Corporate Brokership

RNS Number : 4062E

Futura Medical PLC

26 September 2008

 



For immediate release

26 September 2008

Futura Medical plc

('Futura' or 'the Group' or 'the Company')

 Corporate brokership

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that Canaccord Adams, the Company's Nominated Adviser, is now the Company's sole broker. Canaccord Adams was formerly joint broker to the Company.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.co.uk
Canaccord Adams
Ryan Gaffney / Adria Da Breo Richards	Tel: [phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Rebecca Skye Dietrich	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock

Exchange.

www.futuramedical.co.uk

 

END

 

 

APPPUUCUBUPRGUQ